Vivienne Souter
Overview
Explore the profile of Vivienne Souter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benn P, Wang Y, Gray J, Dugan E, Hajjar M, Prigmore B, et al.
Genet Med
. 2024 Dec;
27(3):101345.
PMID: 39688110
Purpose: To review biotinidase gene (BTD) variants identified in a large, diverse, reproductive carrier screening (RCS) cohort and outline management of heterozygotes with pathogenic or likely pathogenic (P/LP) variants. Methods:...
2.
Gilstrop Thompson M, Xu W, Moore B, Wang T, Sun N, Pewar H, et al.
Obstet Gynecol
. 2024 Nov;
145(2):211-216.
PMID: 39591628
Objective: To present a large U.S. clinical validation of a next-generation sequencing-based, noninvasive prenatal cell-free DNA test for fetal RHD . Methods: This clinical validation study assessed the performance of...
3.
Schrock-Kelley S, Souter V, Hall M, Sha Y, Sengupta U, ElNaggar A, et al.
Commun Med (Lond)
. 2024 Sep;
4(1):185.
PMID: 39349798
Background: Approximately 15% of colorectal cancers (CRCs) are associated with germline mutations. There is increasing adoption of DNA-based assays for molecular residual disease (MRD) and growing evidence supporting its clinical...
4.
Samara A, Souter V, Coutinho C, Khalil A
EClinicalMedicine
. 2024 Aug;
74:102729.
PMID: 39109188
SARS-CoV-2 infection during pregestational and early pregnancy periods has an unclear impact on fetal development. Although vertical transmission is rare, potential effects on the developing fetal brain are plausible. However,...
5.
Khalil A, Ahmed E, Souter V
Am J Obstet Gynecol
. 2024 Jun;
231(5):e191.
PMID: 38876415
No abstract available.
6.
Lengerich B, Caruana R, Painter I, Weeks W, Sitcov K, Souter V
Am J Obstet Gynecol MFM
. 2024 Jun;
6(8):101391.
PMID: 38851393
Background: Early identification of patients at increased risk for postpartum hemorrhage (PPH) associated with severe maternal morbidity (SMM) is critical for preparation and preventative intervention. However, prediction is challenging in...
7.
Souter V, Becraft E, Brummitt S, Gall B, Prigmore B, Wang Y, et al.
Circ Genom Precis Med
. 2024 Mar;
17(2):e004457.
PMID: 38506081
Background: Familial hypercholesterolemia is a treatable genetic condition but remains underdiagnosed. We reviewed the frequency of pathogenic or likely pathogenic (P/LP) variants in the gene in female individuals receiving reproductive...
8.
Khalil A, Bellesia G, Norton M, Jacobsson B, Haeri S, Egbert M, et al.
Am J Obstet Gynecol
. 2024 Mar;
231(5):554.e1-554.e18.
PMID: 38432413
Background: Accurate individualized assessment of preeclampsia risk enables the identification of patients most likely to benefit from initiation of low-dose aspirin at 12 to 16 weeks of gestation when there...
9.
Bosschieter T, Xu Z, Lan H, Lengerich B, Nori H, Painter I, et al.
J Healthc Inform Res
. 2024 Jan;
8(1):65-87.
PMID: 38273984
Although most pregnancies result in a good outcome, complications are not uncommon and can be associated with serious implications for mothers and babies. Predictive modeling has the potential to improve...
10.
Westbrook L, Miltenburg D, Souter V, Maisenbacher M, Howard K, Sha Y, et al.
Breast Cancer Res Treat
. 2023 Oct;
203(2):365-372.
PMID: 37861889
Purpose: Up to 10% of all breast cancers (BC) are attributed to inherited pathogenic variants (PV) in BC susceptibility genes; however, most carriers of PVs remain unidentified. Here, we sought...